Global Advanced Wound Care Market: Focus on Advanced Wound Care Dressings, NPWT Devices, Wound Care Biologics, HBOT Devices, Ultrasonic Devices, and Electromagnetic Devices – Analysis and Forecast, 2018-2024
Hard copy option is available on any of the options above at an additional charge of $500. Please email us at [email protected] with your request.
Key questions answered in the report:
The global advanced wound care market, by products, was valued to be $8,904.6 million in 2018 and is estimated to reach a market value of $11,059.3 million by 2024 at a CAGR of 3.62% from 2019 to 2024.
The market is subject to intense competition and the rising demand by the governments to reduce spending on healthcare is dragging the market growth. However, the future growth is expected to be driven by favorable demographic factors such as growing aging population and rising incidences of chronic wounds.
Expert Quote
“Emerging technologies such as crab shell bandages (involving usage of abundant proteins, chitin, complex hydrogels), bacteriophages, platelets, and stem cell therapy are expected to drive advanced wound care market in future. However, availability of these technologies in the market is a challenge for key players in the market as these products still needs to showcase incremental improvement from current advanced wound care technologies and in order to convince regulators across countries to reimburse these costly treatments such as stem cell therapy. It will take another 5-10 year for these emerging technologies to significantly capture market share from current technologies.”
Scope of the Advanced Wound Care Market
The purpose of this study is to gain a holistic view of the global advanced wound care market in terms of various influencing factors, such as regional adoption trends, and key developments, among others. The scope of this report constitutes of an in-depth study of the market, including a thorough analysis of the products across different regions. The report includes an in-depth examination of the key ecosystem players and key strategies and developments taking place in this market. The report presents the reader with an opportunity to unlock comprehensive insights with respect to the market and helps in forming well-informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into consideration before entering into the market.
Market Segmentation
The report on global advanced wound care market tracks trends, industry participants, and quantifies technologies that facilitates wound healing in conditions where standard wound care therapies fails. These technologies are classified under advanced wound dressings, negative pressure wound therapy, wound biologics and an array of emerging technologies such as oxygen therapy, electric simulation, spray mist, and shockwave therapy.
Diving further deep, this report also discusses and quantifies the various underlying conditions for wounds, wound care global burden, and application of advanced wound care in the management of chronic and acute wounds.
The above analysis is conducted at a regional and country level and markets have been sized and forecasted by considering impact of various trends. Major industry participants and their products have been thoroughly analyzed and forecasts of their performance, market share, and growth rates have been provided. The report considers 2018 as the base year and forecasts the market for the period of 2019-2024.
Key Companies in the Advanced Wound Care Market
Acelity (3M), Smith and Nephew, Molnlycke, ConvaTec, Coloplast, Hartmann, Integra, BSN Medical, MiMedX, Medline and Organogenesis are some of the leading players in this market.
Key questions answered in the report:
- How big is the advanced wound care market and what is its outlook for future?
- What are the drivers and restraints of this market?
- Which technologies dominate in this advanced wound care market?
- What will be the growth of sub segments of the advanced wound care market (advanced dressings, NPWT, biologics) and their sub-categories (films, alginates, single use NPWT, allograft, and others)?
- How will the advanced wound care market and its sub segments behave in different regions, and countries? What are the expected growth rates?
- What are the characteristics (GDP, disease prevalence, regulations, and reimbursements) of countries that are major market for advanced wound care products?
- What are the key developments in this market- mergers and acquisitions, product launches etc. in past 3 years?
- Who are the dominant players in this market and its sub-segments?
- What strategies are deployed by leading players to maintain market share?
The global advanced wound care market, by products, was valued to be $8,904.6 million in 2018 and is estimated to reach a market value of $11,059.3 million by 2024 at a CAGR of 3.62% from 2019 to 2024.
The market is subject to intense competition and the rising demand by the governments to reduce spending on healthcare is dragging the market growth. However, the future growth is expected to be driven by favorable demographic factors such as growing aging population and rising incidences of chronic wounds.
Expert Quote
“Emerging technologies such as crab shell bandages (involving usage of abundant proteins, chitin, complex hydrogels), bacteriophages, platelets, and stem cell therapy are expected to drive advanced wound care market in future. However, availability of these technologies in the market is a challenge for key players in the market as these products still needs to showcase incremental improvement from current advanced wound care technologies and in order to convince regulators across countries to reimburse these costly treatments such as stem cell therapy. It will take another 5-10 year for these emerging technologies to significantly capture market share from current technologies.”
Scope of the Advanced Wound Care Market
The purpose of this study is to gain a holistic view of the global advanced wound care market in terms of various influencing factors, such as regional adoption trends, and key developments, among others. The scope of this report constitutes of an in-depth study of the market, including a thorough analysis of the products across different regions. The report includes an in-depth examination of the key ecosystem players and key strategies and developments taking place in this market. The report presents the reader with an opportunity to unlock comprehensive insights with respect to the market and helps in forming well-informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into consideration before entering into the market.
Market Segmentation
The report on global advanced wound care market tracks trends, industry participants, and quantifies technologies that facilitates wound healing in conditions where standard wound care therapies fails. These technologies are classified under advanced wound dressings, negative pressure wound therapy, wound biologics and an array of emerging technologies such as oxygen therapy, electric simulation, spray mist, and shockwave therapy.
Diving further deep, this report also discusses and quantifies the various underlying conditions for wounds, wound care global burden, and application of advanced wound care in the management of chronic and acute wounds.
The above analysis is conducted at a regional and country level and markets have been sized and forecasted by considering impact of various trends. Major industry participants and their products have been thoroughly analyzed and forecasts of their performance, market share, and growth rates have been provided. The report considers 2018 as the base year and forecasts the market for the period of 2019-2024.
Key Companies in the Advanced Wound Care Market
Acelity (3M), Smith and Nephew, Molnlycke, ConvaTec, Coloplast, Hartmann, Integra, BSN Medical, MiMedX, Medline and Organogenesis are some of the leading players in this market.
Executive Summary
1 PRODUCT DEFINITION
2 SCOPE OF THE REPORT
3 RESEARCH METHODOLOGY
3.1 Research Methodology
3.2 Data Sources
3.2.1 Secondary Research Data Sources
3.2.2 Primary Data Sources
4 INDUSTRY ANALYSIS
4.1 Industry Evolution
4.2 Wound Management Cost and Supply Chain Analysis
4.3 Legal and Regulatory Framework
5 COMPETITIVE LANDSCAPE
5.1 Vendor Share Analysis
5.2 Key Strategies and Developments
5.2.1 Product Launch and Updates
5.2.2 Mergers and Acquisitions
5.3 Product Mapping
5.4 Competitive Benchmark Mapping
6 GLOBAL ADVANCED WOUND CARE MARKET (BY PRODUCT)
6.1 Overview
6.2 Advanced Wound Dressing
6.2.1 Film Dressing
6.2.2 Foam Dressing
6.2.3 Hydrofiber Dressing
6.2.4 Hydrocolloids Dressing
6.2.5 Hydrogel Dressing
6.2.6 Collagen Dressing
6.2.7 Alginate Dressing
6.2.8 Antimicrobial Dressing
6.3 Negative Pressure Wound Therapies (NPWT Devices)
6.3.1 Conventional Negative Pressure Wound Therapy
6.3.1.1 Canisters
6.3.1.2 Pumps
6.3.1.3 Dressing Kits
6.3.2 Single-Use Negative Pressure Wound Therapy
6.4 Biologics
6.4.1 Skin/Dermal Substitutes
6.4.1.1 Allograft
6.4.1.2 Xenograft
6.4.1.3 Placenta/Amniotic Tissue
6.4.1.4 Bioengineered skin/synthetic Substitutes
6.4.2 Growth Factors
6.4.3 Topical Agents
6.5 Other Advanced Wound Care Products
6.5.1 Hyperbaric Oxygen Therapy
6.5.2 Ultrasonic Mist and Electrical Simulation Devices
7 GLOBAL ADVANCE WOUND CARE THERAPY MARKET (BY WOUND TYPE)
7.1 Overview
7.2 Chronic Wounds
7.2.1 Pressure Ulcer (PU)
7.2.2 Venous Leg Ulcer (VLU)
7.2.3 Diabetic Foot Ulcer (DFU)
7.3 Acute Wounds
8 GLOBAL ADVANCED WOUND CARE MARKET (BY REGION)
8.1 North America
8.1.1 U.S.
8.1.2 Canada
8.2 Europe
8.2.1 U.K.
8.2.2 Germany
8.3 Asia-Pacific
8.3.1 Japan
8.3.2 China
8.4 Rest-of-the-World (RoW)
8.4.1 Brazil
9 COMPANY PROFILES
9.1 3M
9.1.1 Company Overview
9.1.2 Role of 3M in the Global Advanced Wound Care Market
9.1.3 Financials
9.1.4 SWOT Analysis
9.2 Acelity
9.2.1 Company Overview
9.2.2 Role of Acelity in the Global Advance Wound Care Market
9.2.3 Financials
9.2.4 SWOT Analysis
9.3 B. Braun
9.3.1 Company Overview
9.3.2 Role of B. Braun in the Global Advance Wound Care Market
9.3.3 Financials
9.3.4 SWOT Analysis
9.4 Coloplast A/S
9.4.1 Company Overview
9.4.2 Role of Coloplast A/S in the Global Advanced Wound Care Market
9.4.3 Financials
9.4.4 SWOT Analysis
9.5 ConvaTec Group Plc
9.5.1 Company Overview
9.5.2 Role of ConvaTec Group Plc in the Global Advanced Wound Care Market
9.5.3 Financials
9.5.4 SWOT Analysis
9.6 Essity Aktiebolag
9.6.1 Company Overview
9.6.2 Role of Essity Aktiebolag in the Global Advance Wound Care Market
9.6.3 Financials
9.6.4 SWOT Analysis
9.7 Integra LifeSciences Corporation
9.7.1 Company Overview
9.7.2 Role of Integra LifeSciences Corporation in the Global Advance Wound Care Market
9.7.3 Financials
9.7.4 SWOT Analysis
9.8 Medline Industries, Inc.
9.8.1 Company Overview
9.8.2 Role of Medline Industries, Inc. in the Global Advance Wound Care Market
9.8.3 SWOT Analysis
9.9 Mцlnlycke Health Care AB
9.9.1 Company Overview
9.9.2 Role of Mцlnlycke Health Care AB in the Global Advanced Wound Care Market
9.9.3 SWOT Analysis
9.10 MIMEDX GROUP, INC.
9.10.1 Company Overview
9.10.2 Role of MiMedX in the Global Advance Wound Care Market
9.10.3 Mimedx: Financials
9.10.4 SWOT Analysis
9.11 Organogenesis Inc.
9.11.1 Company Overview
9.11.2 Role of Organogenesis Inc. in the Global Advance Wound Care Market
9.11.3 Financials
9.11.4 SWOT Analysis
9.12 Osiris Therapeutics Inc.
9.12.1 Company Overview
9.12.2 Role of Osiris Therapeutics in the Global Advance Wound Care Market
9.12.3 Financials
9.12.4 SWOT Analysis
9.13 PAUL HARTMANN AG
9.13.1 Company Overview
9.13.2 Role of PAUL HARTMANN AG in the Global Advance Wound Care Market
9.13.3 Financials
9.13.4 SWOT Analysis
9.14 Smith & Nephew Plc
9.14.1 Company Overview
9.14.2 Role of Smith & Nephew Plc in the Global Advance Wound Care Market
9.14.3 Financials
9.14.4 SWOT Analysis
1 PRODUCT DEFINITION
2 SCOPE OF THE REPORT
3 RESEARCH METHODOLOGY
3.1 Research Methodology
3.2 Data Sources
3.2.1 Secondary Research Data Sources
3.2.2 Primary Data Sources
4 INDUSTRY ANALYSIS
4.1 Industry Evolution
4.2 Wound Management Cost and Supply Chain Analysis
4.3 Legal and Regulatory Framework
5 COMPETITIVE LANDSCAPE
5.1 Vendor Share Analysis
5.2 Key Strategies and Developments
5.2.1 Product Launch and Updates
5.2.2 Mergers and Acquisitions
5.3 Product Mapping
5.4 Competitive Benchmark Mapping
6 GLOBAL ADVANCED WOUND CARE MARKET (BY PRODUCT)
6.1 Overview
6.2 Advanced Wound Dressing
6.2.1 Film Dressing
6.2.2 Foam Dressing
6.2.3 Hydrofiber Dressing
6.2.4 Hydrocolloids Dressing
6.2.5 Hydrogel Dressing
6.2.6 Collagen Dressing
6.2.7 Alginate Dressing
6.2.8 Antimicrobial Dressing
6.3 Negative Pressure Wound Therapies (NPWT Devices)
6.3.1 Conventional Negative Pressure Wound Therapy
6.3.1.1 Canisters
6.3.1.2 Pumps
6.3.1.3 Dressing Kits
6.3.2 Single-Use Negative Pressure Wound Therapy
6.4 Biologics
6.4.1 Skin/Dermal Substitutes
6.4.1.1 Allograft
6.4.1.2 Xenograft
6.4.1.3 Placenta/Amniotic Tissue
6.4.1.4 Bioengineered skin/synthetic Substitutes
6.4.2 Growth Factors
6.4.3 Topical Agents
6.5 Other Advanced Wound Care Products
6.5.1 Hyperbaric Oxygen Therapy
6.5.2 Ultrasonic Mist and Electrical Simulation Devices
7 GLOBAL ADVANCE WOUND CARE THERAPY MARKET (BY WOUND TYPE)
7.1 Overview
7.2 Chronic Wounds
7.2.1 Pressure Ulcer (PU)
7.2.2 Venous Leg Ulcer (VLU)
7.2.3 Diabetic Foot Ulcer (DFU)
7.3 Acute Wounds
8 GLOBAL ADVANCED WOUND CARE MARKET (BY REGION)
8.1 North America
8.1.1 U.S.
8.1.2 Canada
8.2 Europe
8.2.1 U.K.
8.2.2 Germany
8.3 Asia-Pacific
8.3.1 Japan
8.3.2 China
8.4 Rest-of-the-World (RoW)
8.4.1 Brazil
9 COMPANY PROFILES
9.1 3M
9.1.1 Company Overview
9.1.2 Role of 3M in the Global Advanced Wound Care Market
9.1.3 Financials
9.1.4 SWOT Analysis
9.2 Acelity
9.2.1 Company Overview
9.2.2 Role of Acelity in the Global Advance Wound Care Market
9.2.3 Financials
9.2.4 SWOT Analysis
9.3 B. Braun
9.3.1 Company Overview
9.3.2 Role of B. Braun in the Global Advance Wound Care Market
9.3.3 Financials
9.3.4 SWOT Analysis
9.4 Coloplast A/S
9.4.1 Company Overview
9.4.2 Role of Coloplast A/S in the Global Advanced Wound Care Market
9.4.3 Financials
9.4.4 SWOT Analysis
9.5 ConvaTec Group Plc
9.5.1 Company Overview
9.5.2 Role of ConvaTec Group Plc in the Global Advanced Wound Care Market
9.5.3 Financials
9.5.4 SWOT Analysis
9.6 Essity Aktiebolag
9.6.1 Company Overview
9.6.2 Role of Essity Aktiebolag in the Global Advance Wound Care Market
9.6.3 Financials
9.6.4 SWOT Analysis
9.7 Integra LifeSciences Corporation
9.7.1 Company Overview
9.7.2 Role of Integra LifeSciences Corporation in the Global Advance Wound Care Market
9.7.3 Financials
9.7.4 SWOT Analysis
9.8 Medline Industries, Inc.
9.8.1 Company Overview
9.8.2 Role of Medline Industries, Inc. in the Global Advance Wound Care Market
9.8.3 SWOT Analysis
9.9 Mцlnlycke Health Care AB
9.9.1 Company Overview
9.9.2 Role of Mцlnlycke Health Care AB in the Global Advanced Wound Care Market
9.9.3 SWOT Analysis
9.10 MIMEDX GROUP, INC.
9.10.1 Company Overview
9.10.2 Role of MiMedX in the Global Advance Wound Care Market
9.10.3 Mimedx: Financials
9.10.4 SWOT Analysis
9.11 Organogenesis Inc.
9.11.1 Company Overview
9.11.2 Role of Organogenesis Inc. in the Global Advance Wound Care Market
9.11.3 Financials
9.11.4 SWOT Analysis
9.12 Osiris Therapeutics Inc.
9.12.1 Company Overview
9.12.2 Role of Osiris Therapeutics in the Global Advance Wound Care Market
9.12.3 Financials
9.12.4 SWOT Analysis
9.13 PAUL HARTMANN AG
9.13.1 Company Overview
9.13.2 Role of PAUL HARTMANN AG in the Global Advance Wound Care Market
9.13.3 Financials
9.13.4 SWOT Analysis
9.14 Smith & Nephew Plc
9.14.1 Company Overview
9.14.2 Role of Smith & Nephew Plc in the Global Advance Wound Care Market
9.14.3 Financials
9.14.4 SWOT Analysis
LIST OF TABLES
Table 3.1: Research Parameters
Table 4.1: Reimbursement Situation for NPWT in Europe
Table 5.1: Product Launch and Updates
Table 5.2: Mergers and Acquisitions
Table 6.1: Major Film Dressings, by brand, by, manufacturer
Table 6.2: Major Foam Dressings, by brand, by manufacturer
Table 6.3: Major Hydrocolloid Dressings, by brand, by manufacturer
Table 6.4: Major Hydrogel Dressings, by brand, by manufacturer
Table 6.5: Major Collagen Dressings, by brand, by manufacturer
Table 6.6: Major Alginate Dressings, by brand, by manufacturer
Table 6.7: Major Antimicrobial Dressings, by brand, by manufacturer
Table 7.1: Major Wound Types
Table 7.2: Global Pressure Ulcer Statistics
Table 7.3: Global Venous Leg Ulcer Statistics
Table 7.4: Global Diabetes Statistics
Table 7.5: Global Diabetic Foot Ulcer Statistics
Table 3.1: Research Parameters
Table 4.1: Reimbursement Situation for NPWT in Europe
Table 5.1: Product Launch and Updates
Table 5.2: Mergers and Acquisitions
Table 6.1: Major Film Dressings, by brand, by, manufacturer
Table 6.2: Major Foam Dressings, by brand, by manufacturer
Table 6.3: Major Hydrocolloid Dressings, by brand, by manufacturer
Table 6.4: Major Hydrogel Dressings, by brand, by manufacturer
Table 6.5: Major Collagen Dressings, by brand, by manufacturer
Table 6.6: Major Alginate Dressings, by brand, by manufacturer
Table 6.7: Major Antimicrobial Dressings, by brand, by manufacturer
Table 7.1: Major Wound Types
Table 7.2: Global Pressure Ulcer Statistics
Table 7.3: Global Venous Leg Ulcer Statistics
Table 7.4: Global Diabetes Statistics
Table 7.5: Global Diabetic Foot Ulcer Statistics
LIST OF FIGURES
Figure 1: Global Advanced Wound Care Market, 2018-2024
Figure 2: Advanced Wound Care, Market Share 2018
Figure 3: Advanced Wound Care Technology Products, 2018 and 2024
Figure 4: Growth Share Matrix, Advanced Wound Care Technology, by Product segments
Figure 5: Expected Growth Rates, Advanced Wound Care Technology, by Sub-Product segments
Figure 6: Advanced Wound Dressing, Market Share 2018
Figure 7: Negative Pressure Wound Therapies, Market Share 2018
Figure 8: Wound Biologics, Market Share 2018
Figure 9: Advanced Wound Care Market, by regions, 2018 and 2024
Figure 10: Growth Share Matrix, Advanced Wound Care Technology, by Countries
Figure 2.1: Advanced Wound Care: Market Segmentation
Figure 4.1: Industry Trends in Advanced Wound Care Market
Figure 4.2: Cost Breakup, Wound Management Life Cycle
Figure 5.1: Advanced Wound Care, Market Share 2018
Figure 5.2: Advanced Wound Care, Market Share 2024
Figure 5.3: Advanced Wound Care Market, Key Developments, 2016-2019
Figure 5.4: Advanced Wound Care Market, Activity Instances by Companies, 2016-2019
Figure 5.5: Growth Share Matrix, by Companies
Figure 6.1: Global Advanced Wound Care Market, 2018-2024
Figure 6.2: Advanced Wound Care Technology Products
Figure 6.3: Advanced Wound Care Technology Products
Figure 6.4: Global Advanced Wound Dressing Market, 2018-2024
Figure 6.5: Global Advanced Dressings Market, by Types
Figure 6.6: Advanced Wound Dressing, Market Share 2018
Figure 6.7: Advanced Wound Dressing, Market Share 2024
Figure 6.8: Global Film Advanced Wound Dressing Market ($Million), 2018-2024
Figure 6.9: Global Foam Advanced Wound Dressing Market ($Million), 2018-2024
Figure 6.10: Global Hydrofiber Advanced Wound Dressing Market ($Million), 2018-2024
Figure 6.11: Global Hydrocolloids Advanced Wound Dressing Market ($Million), 2018-2024
Figure 6.12: Global Hydrogel Advanced Wound Dressing Market ($Million), 2018-2024
Figure 6.13: Global Collagen Advanced Wound Dressing Market ($Million), 2018-2024
Figure 6.14: Global Alginate Advanced Wound Dressing Market ($Million), 2018-2024
Figure 6.15: Global Antimicrobial Advanced Wound Dressing Market ($Million), 2018-2024
Figure 6.16: Global Negative Pressure Wound Therapies Market ($Million), 2018 and 2024
Figure 6.17: Negative Pressure Wound Therapies, Market Share 2018
Figure 6.18: Negative Pressure Wound Therapies, Market Share 2024
Figure 6.19: Global Conventional NPWT Market ($Million), 2018-2024
Figure 6.20: Global Single Use NPWT Market ($Million), 2018-2024
Figure 6.21: Global Wound Biologics Market ($Million), 2018 and 2024
Figure 6.22: Wound Biologics, Market Share 2018
Figure 6.23: Wound Biologics, Market Share 2024
Figure 6.24: Global Skin/Dermal Substitutes Market, 2018-2024
Figure 6.25: Global Skin/Dermal Substitutes Market, by Types, 2018-2024
Figure 6.26: Global Wound Care Allograft Market, 2018-2024
Figure 6.27: Global Wound Care Xenograft Market, 2018-2024
Figure 6.28: Global Wound Care Placenta/Amniotic Tissue Market, 2018-2024
Figure 6.29: Global Wound Care Bioengineered and Synthetic Skin Market, 2018-2024
Figure 6.30: Global Wound Care Growth Factors Market, $Million, 2018-2024
Figure 6.31: Global Wound Care Topical Agents Market, $Million, 2018-2024
Figure 6.32: Global Hyperbaric Oxygen Therapy Market, $Million, 2018-2024
Figure 6.33: Global Ultrasound Mist and Electrical Simulation Market, $Million, 2018-2024
Figure 7.1: Wound Treatment Scenario
Figure 7.2: Global Advanced Wound Care Market, by Wound Type, 2018 and 2024
Figure 7.3: Global Chronic Wound Care Market, $Million, 2018-2024
Figure 7.4: Global Chronic Wound Care Market, by Disease Types, 2018-2024
Figure 7.5: Global Pressure Ulcer Advanced Wound Care Market ($Million), 2018-2024
Figure 7.6: Global Venous Leg Ulcer Advanced Wound Care Market ($Million), 2018-2024
Figure 7.7: Global Diabetic Foot Ulcer Advanced Wound Care Market ($Million), 2018-2024
Figure 7.8: Global Acute Advanced Wound Care Market ($Million), 2018-2024
Figure 8.1: Advanced Wound Care Market, by regions, 2018 and 2024
Figure 8.2: Snapshot
Figure 8.3: North America Advanced Wound Management Market, by Products, 2018-2024
Figure 8.4: North America Advanced Wound Care Market ($Million), by Countries 2018-2024
Figure 8.5: Snapshot
Figure 8.6: The U.S. Advanced Wound Care Market ($Million), 2018-2024
Figure 8.7: Snapshot
Figure 8.8: Canada Advanced Wound Care Market ($Million), 2018-2024
Figure 8.9: Snapshot
Figure 8.10: Europe Advanced Wound Management Market, by Products, 2018-2024
Figure 8.11: Europe Advanced Wound Care Market ($Million), by Countries 2018-2024
Figure 8.12: Snapshot
Figure 8.13: UK Advanced Wound Care Market ($Million), 2018-2024
Figure 8.14: Snapshot
Figure 8.15: Germany Advanced Wound Care Market ($Million), 2018-2024
Figure 8.16: Snapshot
Figure 8.17: Asia-Pacific Advanced Wound Management Market, by Products, 2018-2024
Figure 8.18: Asia-Pacific Advanced Wound Care Market ($Million), by Countries 2018-2024
Figure 8.19: Snapshot
Figure 8.20: Japan Advanced Wound Care Market ($Million), 2018-2024
Figure 8.21: Snapshot
Figure 8.22: China Advanced Wound Care Market ($Million), 2018-2024
Figure 8.23: Snapshot
Figure 8.24: Rest-of-the-World Advanced Wound Management Market, by Products, 2018-2024
Figure 8.25: Rest-of-the-World Advanced Wound Care Market ($Million), by Countries 2018-2024
Figure 8.26: Snapshot
Figure 8.27: Brazil Advanced Wound Care Market ($Million), 2018-2024
Figure 9.1: 3M: Advanced Wound Care Product Portfolio
Figure 9.2: 3M, Overall Financials, 2016-2018
Figure 9.3: 3M, Total Sales Revenue (by Segment), 2016-2018
Figure 9.4: 3M, Total Sales Revenue (by Region), 2016-2018
Figure 9.5: 3M, Total Sales Revenue, 2016-2018
Figure 9.6: 3M: SWOT Analysis
Figure 9.7: Acelity: Advanced Wound Care Product Portfolio
Figure 9.8: Acelity, Overall Financials, 2016-2018
Figure 9.9: Acelity, Total Sales Revenue (by Segment), 2016-2018
Figure 9.10: Acelity (by Region), 2016-2018
Figure 9.11: Acelity, Total Sales Revenue, 2016-2018
Figure 9.12: Acelity: SWOT Analysis
Figure 9.13: B. Braun: Advanced Wound Care Product Portfolio
Figure 9.14: B. Braun, Overall Financials, 2016-2018
Figure 9.15: B. Braun, Total Sales Revenue (by Segment), 2016-2018
Figure 9.16: B. Braun (by Region), 2016-2018
Figure 9.17: B. Braun, Total Sales Revenue, 2016-2018
Figure 9.18: B. Braun: SWOT Analysis
Figure 9.19: Coloplast A/S: Advanced Wound Care Product Portfolio
Figure 9.20: Coloplast A/S, Overall Financials, 2016-2018
Figure 9.21: Coloplast A/S, Total Sales Revenue (by Segment), 2016-2018
Figure 9.22: Coloplast A/S (by Region), 2016-2018
Figure 9.23: Coloplast A/S, Total Sales Revenue, 2016-2018
Figure 9.24: Coloplast A/S: SWOT Analysis
Figure 9.25: ConvaTec Group PLC: Advanced Wound Care Product Portfolio
Figure 9.26: ConvaTec Group PLC, Overall Financials, 2016-2018
Figure 9.27: ConvaTec Group Plc, Total Sales Revenue (by Segment), 2016-2018
Figure 9.28: ConvaTec Group PLC (by Region), 2016-2018
Figure 9.29: ConvaTec Group PLC, Total Sales Revenue, 2016-2018
Figure 9.30: ConvaTec Group PLC: SWOT Analysis
Figure 9.31: Essity Aktiebolag: Advanced Wound Care Product Portfolio
Figure 9.32: Essity Aktiebolag, Overall Financials, 2016-2018
Figure 9.33: Essity Aktiebolag, Total Sales Revenue (by Segment), 2016-2018
Figure 9.34: Essity Aktiebolag (by Region), 2016-2018
Figure 9.35: Essity Aktiebolag, Total Sales Revenue, 2016-2018
Figure 9.36: Essity Aktiebolag: SWOT Analysis
Figure 9.37: Integra LifeSciences Corporation: Advanced Wound Care Product Portfolio
Figure 9.38: Integra LifeSciences Corporation, Overall Financials, 2016-2018
Figure 9.39: Integra LifeSciences Corporation, Total Sales Revenue (by Segment), 2016-2018
Figure 9.40: Integra LifeSciences Corporation (by Region), 2016-2018
Figure 9.41: Integra LifeSciences Corporation, Total Sales Revenue, 2016-2018
Figure 9.42: Integra LifeSciences Corporation: SWOT Analysis
Figure 9.43: Medline Industries, Inc.: Advanced Wound Care Product Portfolio
Figure 9.44: Medline Industries, Inc.: SWOT Analysis
Figure 9.45: Mцlnlycke Health Care AB: Advanced Wound Care Product Portfolio
Figure 9.46: Mцlnlycke Health Care AB: SWOT Analysis
Figure 9.47: MiMedX: Advanced Wound Care Product Portfolio
Figure 9.48: MiMedx: SWOT Analysis
Figure 9.49: Organogenesis Inc.: Advanced Wound Care Product Portfolio
Figure 9.50: Organogenesis Inc., Overall Financials, 2016-2018
Figure 9.51: Organogenesis Inc., Total Sales Revenue (by Segment), 2016-2018
Figure 9.52: Organogenesis Inc., Total Sales Revenue, 2016-2018
Figure 9.53: Organogenesis Inc.: SWOT Analysis
Figure 9.54: Osiris Therapeutics: Wound Care Product Portfolio
Figure 9.55: Osiris Therapeutics, Overall Financials, 2016-2018
Figure 9.56: Osiris Therapeutics, Total Sales Revenue (by Segments and Products), 2016-2018
Figure 9.57: Osiris Therapeutics, Total Sales Revenue, 2016-2018
Figure 9.58: Osiris Therapeutics: SWOT Analysis
Figure 9.59: PAUL HARTMANN AG: Product Portfolio
Figure 9.60: PAUL HARTMANN AG, Overall Financials, 2016-2018
Figure 9.61: PAUL HARTMANN AG, Total Sales Revenue (by Segment), 2016-2018
Figure 9.62: PAUL HARTMANN AG (by Region), 2016-2018
Figure 9.63: PAUL HARTMANN AG, Total Sales Revenue, 2016-2018
Figure 9.64: PAUL HARTMANN AG: SWOT Analysis
Figure 9.65: Smith & Nephew Plc: Advanced Wound Care Product Portfolio
Figure 9.66: Smith & Nephew Plc, Overall Financials, 2016-2018
Figure 9.67: Smith & Nephew Plc, Total Sales Revenue (by Segment), 2016-2018
Figure 9.68: Smith & Nephew Plc (by Region), 2016-2018
Figure 9.69: Smith & Nephew Plc, Total Sales Revenue, 2016-2018
Figure 9.70: Smith & Nephew Plc: SWOT Analysis
Figure 1: Global Advanced Wound Care Market, 2018-2024
Figure 2: Advanced Wound Care, Market Share 2018
Figure 3: Advanced Wound Care Technology Products, 2018 and 2024
Figure 4: Growth Share Matrix, Advanced Wound Care Technology, by Product segments
Figure 5: Expected Growth Rates, Advanced Wound Care Technology, by Sub-Product segments
Figure 6: Advanced Wound Dressing, Market Share 2018
Figure 7: Negative Pressure Wound Therapies, Market Share 2018
Figure 8: Wound Biologics, Market Share 2018
Figure 9: Advanced Wound Care Market, by regions, 2018 and 2024
Figure 10: Growth Share Matrix, Advanced Wound Care Technology, by Countries
Figure 2.1: Advanced Wound Care: Market Segmentation
Figure 4.1: Industry Trends in Advanced Wound Care Market
Figure 4.2: Cost Breakup, Wound Management Life Cycle
Figure 5.1: Advanced Wound Care, Market Share 2018
Figure 5.2: Advanced Wound Care, Market Share 2024
Figure 5.3: Advanced Wound Care Market, Key Developments, 2016-2019
Figure 5.4: Advanced Wound Care Market, Activity Instances by Companies, 2016-2019
Figure 5.5: Growth Share Matrix, by Companies
Figure 6.1: Global Advanced Wound Care Market, 2018-2024
Figure 6.2: Advanced Wound Care Technology Products
Figure 6.3: Advanced Wound Care Technology Products
Figure 6.4: Global Advanced Wound Dressing Market, 2018-2024
Figure 6.5: Global Advanced Dressings Market, by Types
Figure 6.6: Advanced Wound Dressing, Market Share 2018
Figure 6.7: Advanced Wound Dressing, Market Share 2024
Figure 6.8: Global Film Advanced Wound Dressing Market ($Million), 2018-2024
Figure 6.9: Global Foam Advanced Wound Dressing Market ($Million), 2018-2024
Figure 6.10: Global Hydrofiber Advanced Wound Dressing Market ($Million), 2018-2024
Figure 6.11: Global Hydrocolloids Advanced Wound Dressing Market ($Million), 2018-2024
Figure 6.12: Global Hydrogel Advanced Wound Dressing Market ($Million), 2018-2024
Figure 6.13: Global Collagen Advanced Wound Dressing Market ($Million), 2018-2024
Figure 6.14: Global Alginate Advanced Wound Dressing Market ($Million), 2018-2024
Figure 6.15: Global Antimicrobial Advanced Wound Dressing Market ($Million), 2018-2024
Figure 6.16: Global Negative Pressure Wound Therapies Market ($Million), 2018 and 2024
Figure 6.17: Negative Pressure Wound Therapies, Market Share 2018
Figure 6.18: Negative Pressure Wound Therapies, Market Share 2024
Figure 6.19: Global Conventional NPWT Market ($Million), 2018-2024
Figure 6.20: Global Single Use NPWT Market ($Million), 2018-2024
Figure 6.21: Global Wound Biologics Market ($Million), 2018 and 2024
Figure 6.22: Wound Biologics, Market Share 2018
Figure 6.23: Wound Biologics, Market Share 2024
Figure 6.24: Global Skin/Dermal Substitutes Market, 2018-2024
Figure 6.25: Global Skin/Dermal Substitutes Market, by Types, 2018-2024
Figure 6.26: Global Wound Care Allograft Market, 2018-2024
Figure 6.27: Global Wound Care Xenograft Market, 2018-2024
Figure 6.28: Global Wound Care Placenta/Amniotic Tissue Market, 2018-2024
Figure 6.29: Global Wound Care Bioengineered and Synthetic Skin Market, 2018-2024
Figure 6.30: Global Wound Care Growth Factors Market, $Million, 2018-2024
Figure 6.31: Global Wound Care Topical Agents Market, $Million, 2018-2024
Figure 6.32: Global Hyperbaric Oxygen Therapy Market, $Million, 2018-2024
Figure 6.33: Global Ultrasound Mist and Electrical Simulation Market, $Million, 2018-2024
Figure 7.1: Wound Treatment Scenario
Figure 7.2: Global Advanced Wound Care Market, by Wound Type, 2018 and 2024
Figure 7.3: Global Chronic Wound Care Market, $Million, 2018-2024
Figure 7.4: Global Chronic Wound Care Market, by Disease Types, 2018-2024
Figure 7.5: Global Pressure Ulcer Advanced Wound Care Market ($Million), 2018-2024
Figure 7.6: Global Venous Leg Ulcer Advanced Wound Care Market ($Million), 2018-2024
Figure 7.7: Global Diabetic Foot Ulcer Advanced Wound Care Market ($Million), 2018-2024
Figure 7.8: Global Acute Advanced Wound Care Market ($Million), 2018-2024
Figure 8.1: Advanced Wound Care Market, by regions, 2018 and 2024
Figure 8.2: Snapshot
Figure 8.3: North America Advanced Wound Management Market, by Products, 2018-2024
Figure 8.4: North America Advanced Wound Care Market ($Million), by Countries 2018-2024
Figure 8.5: Snapshot
Figure 8.6: The U.S. Advanced Wound Care Market ($Million), 2018-2024
Figure 8.7: Snapshot
Figure 8.8: Canada Advanced Wound Care Market ($Million), 2018-2024
Figure 8.9: Snapshot
Figure 8.10: Europe Advanced Wound Management Market, by Products, 2018-2024
Figure 8.11: Europe Advanced Wound Care Market ($Million), by Countries 2018-2024
Figure 8.12: Snapshot
Figure 8.13: UK Advanced Wound Care Market ($Million), 2018-2024
Figure 8.14: Snapshot
Figure 8.15: Germany Advanced Wound Care Market ($Million), 2018-2024
Figure 8.16: Snapshot
Figure 8.17: Asia-Pacific Advanced Wound Management Market, by Products, 2018-2024
Figure 8.18: Asia-Pacific Advanced Wound Care Market ($Million), by Countries 2018-2024
Figure 8.19: Snapshot
Figure 8.20: Japan Advanced Wound Care Market ($Million), 2018-2024
Figure 8.21: Snapshot
Figure 8.22: China Advanced Wound Care Market ($Million), 2018-2024
Figure 8.23: Snapshot
Figure 8.24: Rest-of-the-World Advanced Wound Management Market, by Products, 2018-2024
Figure 8.25: Rest-of-the-World Advanced Wound Care Market ($Million), by Countries 2018-2024
Figure 8.26: Snapshot
Figure 8.27: Brazil Advanced Wound Care Market ($Million), 2018-2024
Figure 9.1: 3M: Advanced Wound Care Product Portfolio
Figure 9.2: 3M, Overall Financials, 2016-2018
Figure 9.3: 3M, Total Sales Revenue (by Segment), 2016-2018
Figure 9.4: 3M, Total Sales Revenue (by Region), 2016-2018
Figure 9.5: 3M, Total Sales Revenue, 2016-2018
Figure 9.6: 3M: SWOT Analysis
Figure 9.7: Acelity: Advanced Wound Care Product Portfolio
Figure 9.8: Acelity, Overall Financials, 2016-2018
Figure 9.9: Acelity, Total Sales Revenue (by Segment), 2016-2018
Figure 9.10: Acelity (by Region), 2016-2018
Figure 9.11: Acelity, Total Sales Revenue, 2016-2018
Figure 9.12: Acelity: SWOT Analysis
Figure 9.13: B. Braun: Advanced Wound Care Product Portfolio
Figure 9.14: B. Braun, Overall Financials, 2016-2018
Figure 9.15: B. Braun, Total Sales Revenue (by Segment), 2016-2018
Figure 9.16: B. Braun (by Region), 2016-2018
Figure 9.17: B. Braun, Total Sales Revenue, 2016-2018
Figure 9.18: B. Braun: SWOT Analysis
Figure 9.19: Coloplast A/S: Advanced Wound Care Product Portfolio
Figure 9.20: Coloplast A/S, Overall Financials, 2016-2018
Figure 9.21: Coloplast A/S, Total Sales Revenue (by Segment), 2016-2018
Figure 9.22: Coloplast A/S (by Region), 2016-2018
Figure 9.23: Coloplast A/S, Total Sales Revenue, 2016-2018
Figure 9.24: Coloplast A/S: SWOT Analysis
Figure 9.25: ConvaTec Group PLC: Advanced Wound Care Product Portfolio
Figure 9.26: ConvaTec Group PLC, Overall Financials, 2016-2018
Figure 9.27: ConvaTec Group Plc, Total Sales Revenue (by Segment), 2016-2018
Figure 9.28: ConvaTec Group PLC (by Region), 2016-2018
Figure 9.29: ConvaTec Group PLC, Total Sales Revenue, 2016-2018
Figure 9.30: ConvaTec Group PLC: SWOT Analysis
Figure 9.31: Essity Aktiebolag: Advanced Wound Care Product Portfolio
Figure 9.32: Essity Aktiebolag, Overall Financials, 2016-2018
Figure 9.33: Essity Aktiebolag, Total Sales Revenue (by Segment), 2016-2018
Figure 9.34: Essity Aktiebolag (by Region), 2016-2018
Figure 9.35: Essity Aktiebolag, Total Sales Revenue, 2016-2018
Figure 9.36: Essity Aktiebolag: SWOT Analysis
Figure 9.37: Integra LifeSciences Corporation: Advanced Wound Care Product Portfolio
Figure 9.38: Integra LifeSciences Corporation, Overall Financials, 2016-2018
Figure 9.39: Integra LifeSciences Corporation, Total Sales Revenue (by Segment), 2016-2018
Figure 9.40: Integra LifeSciences Corporation (by Region), 2016-2018
Figure 9.41: Integra LifeSciences Corporation, Total Sales Revenue, 2016-2018
Figure 9.42: Integra LifeSciences Corporation: SWOT Analysis
Figure 9.43: Medline Industries, Inc.: Advanced Wound Care Product Portfolio
Figure 9.44: Medline Industries, Inc.: SWOT Analysis
Figure 9.45: Mцlnlycke Health Care AB: Advanced Wound Care Product Portfolio
Figure 9.46: Mцlnlycke Health Care AB: SWOT Analysis
Figure 9.47: MiMedX: Advanced Wound Care Product Portfolio
Figure 9.48: MiMedx: SWOT Analysis
Figure 9.49: Organogenesis Inc.: Advanced Wound Care Product Portfolio
Figure 9.50: Organogenesis Inc., Overall Financials, 2016-2018
Figure 9.51: Organogenesis Inc., Total Sales Revenue (by Segment), 2016-2018
Figure 9.52: Organogenesis Inc., Total Sales Revenue, 2016-2018
Figure 9.53: Organogenesis Inc.: SWOT Analysis
Figure 9.54: Osiris Therapeutics: Wound Care Product Portfolio
Figure 9.55: Osiris Therapeutics, Overall Financials, 2016-2018
Figure 9.56: Osiris Therapeutics, Total Sales Revenue (by Segments and Products), 2016-2018
Figure 9.57: Osiris Therapeutics, Total Sales Revenue, 2016-2018
Figure 9.58: Osiris Therapeutics: SWOT Analysis
Figure 9.59: PAUL HARTMANN AG: Product Portfolio
Figure 9.60: PAUL HARTMANN AG, Overall Financials, 2016-2018
Figure 9.61: PAUL HARTMANN AG, Total Sales Revenue (by Segment), 2016-2018
Figure 9.62: PAUL HARTMANN AG (by Region), 2016-2018
Figure 9.63: PAUL HARTMANN AG, Total Sales Revenue, 2016-2018
Figure 9.64: PAUL HARTMANN AG: SWOT Analysis
Figure 9.65: Smith & Nephew Plc: Advanced Wound Care Product Portfolio
Figure 9.66: Smith & Nephew Plc, Overall Financials, 2016-2018
Figure 9.67: Smith & Nephew Plc, Total Sales Revenue (by Segment), 2016-2018
Figure 9.68: Smith & Nephew Plc (by Region), 2016-2018
Figure 9.69: Smith & Nephew Plc, Total Sales Revenue, 2016-2018
Figure 9.70: Smith & Nephew Plc: SWOT Analysis
